{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:13:18Z","timestamp":1788250398073,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.coi.2025.102579","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T14:51:55Z","timestamp":1749048715000},"page":"102579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Animal models of autoimmune encephalitis"],"prefix":"10.1016","volume":"95","author":[{"given":"Estibaliz","family":"Maudes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Planagum\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5856-2813","authenticated-orcid":false,"given":"Josep","family":"Dalmau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2025.102579_bib1","series-title":"Autoimmune Encephalitis and Related Disorders of the Nervous System","author":"Dalmau","year":"2022"},{"key":"10.1016\/j.coi.2025.102579_bib2","series-title":"Handbook of Clinical Neurology","first-page":"11","article-title":"Changing landscape in the field of paraneoplastic neurology: personal perspectives over a 35-year career","author":"Dalmau","year":"2024"},{"key":"10.1016\/j.coi.2025.102579_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/brain\/awv324","article-title":"Human autoantibodies to amphiphysin induce defective presynaptic vesicle dynamics and composition","volume":"139","author":"Werner","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102579_bib4","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1212\/WNL.0000000000012191","article-title":"Clinical, neuroimmunologic, and CSF investigations in first episode psychosis","volume":"97","author":"Guasp","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.coi.2025.102579_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.coi.2025.102579_bib6","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1093\/brain\/awad238","article-title":"Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studies","volume":"146","author":"Armangue","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102579_bib7","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1172\/JCI125178","article-title":"Autoimmune seizures and epilepsy","volume":"129","author":"Geis","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2025.102579_bib8","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/brain\/awh526","article-title":"Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates","volume":"128","author":"Ances","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102579_bib9","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.coi.2025.102579_bib10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/physrev.00010.2016","article-title":"Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system","volume":"97","author":"Dalmau","year":"2017","journal-title":"Physiol Rev"},{"key":"10.1016\/j.coi.2025.102579_bib11","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.coi.2025.102579_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuron.2018.07.048","article-title":"Human autoantibodies against the AMPA receptor subunit GluA2 induce receptor reorganization and memory dysfunction","volume":"100","author":"Haselmann","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.coi.2025.102579_bib13","doi-asserted-by":"crossref","first-page":"8151","DOI":"10.1523\/JNEUROSCI.4415-13.2014","article-title":"Identification and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitis","volume":"34","author":"Ohkawa","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.coi.2025.102579_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ana.26098","article-title":"Encephalitis with autoantibodies against the Glutamate Kainate Receptors GluK2","volume":"90","author":"Landa","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coi.2025.102579_bib15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e318228c136","article-title":"Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis","volume":"77","author":"Martinez-Hernandez","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.coi.2025.102579_bib16","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102579_bib17","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1172\/JCI122942","article-title":"Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica","volume":"129","author":"Soltys","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2025.102579_bib18","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/ene.12758","article-title":"The expanding field of IgG4-mediated neurological autoimmune disorders","volume":"22","author":"Huijbers","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.coi.2025.102579_bib19","first-page":"3144","article-title":"LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory","volume":"141","author":"Petit-Pedrol","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102579_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ana.25120","article-title":"Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia","volume":"83","author":"Patterson","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coi.2025.102579_bib21","article-title":"Patients' IgLON5 autoantibodies interfere with IgLON5-protein interactions","volume":"14","author":"Landa","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102579_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-016-0689-1","article-title":"Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome","volume":"13","author":"Sabater","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.coi.2025.102579_bib23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.coi.2025.102579_bib24","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/ana.25857","article-title":"Effects of IgLON5 antibodies on neuronal cytoskeleton: a link between autoimmunity and neurodegeneration","volume":"88","author":"Landa","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coi.2025.102579_bib25","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-024-02805-y","article-title":"Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathy","volume":"148","author":"Gelpi","year":"2024","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.coi.2025.102579_bib26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0167-5699(93)90244-F","article-title":"Defining criteria for autoimmune diseases (Witebsky's postulates revisited)","volume":"14","author":"Rose","year":"1993","journal-title":"Immunol Today"},{"key":"10.1016\/j.coi.2025.102579_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/brain\/awu310","article-title":"Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice","volume":"138","author":"Planaguma","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102579_sbref28","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/brain\/awae129","article-title":"Peripherally-derived LGI1-reactive monoclonal antibodies cause epileptic seizures in vivo","volume":"147","author":"Upadhya","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102579_sbref29","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113166","article-title":"Human NMDAR autoantibodies disrupt excitatory-inhibitory balance, leading to hippocampal network hypersynchrony","volume":"42","author":"Ceanga","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2025.102579_bib30","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200261","article-title":"Positive allosteric modulation of NMDARs prevents the altered surface dynamics caused by patients' antibodies","volume":"11","author":"Maudes","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.coi.2025.102579_bib31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ana.25829","article-title":"NMDAR antibodies alter dopamine receptors and cause psychotic behavior in mice","volume":"88","author":"Carceles-Cordon","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coi.2025.102579_bib32","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1093\/brain\/awv257","article-title":"Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model","volume":"138","author":"Wright","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102579_bib33","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/brain\/awaa104","article-title":"Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms","volume":"143","author":"Ramberger","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102579_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bbi.2025.02.018","article-title":"Distinctive seizure signature in the first video case-control study of a naturally-occurring feline autoimmune encephalitis model","volume":"126","author":"Binks","year":"2025","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.coi.2025.102579_bib35","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000915","article-title":"Placental transfer of NMDAR antibodies causes reversible alterations in mice","volume":"8","author":"Garcia-Serra","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.coi.2025.102579_bib36","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ana.25552","article-title":"Human gestational N-methyl-d-aspartate receptor autoantibodies impair neonatal murine brain function","volume":"86","author":"Jurek","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coi.2025.102579_bib37","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000668","article-title":"Pregnancy outcomes in anti-NMDA receptor encephalitis: case series","volume":"7","author":"Joubert","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.coi.2025.102579_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2024-001005","article-title":"Clinical data and reporting quality in NMDAR-antibody encephalitis and pregnancy: a systematic review","volume":"7","author":"Harris","year":"2025","journal-title":"BMJ Neurol Open"},{"key":"10.1016\/j.coi.2025.102579_sbref39","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1038\/s41594-024-01386-4","article-title":"Structural and functional mechanisms of anti-NMDAR autoimmune encephalitis","volume":"31","author":"Michalski","year":"2024","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coi.2025.102579_sbref40","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/s41594-024-01387-3","article-title":"Structural basis for antibody-mediated NMDA receptor clustering and endocytosis in autoimmune encephalitis","volume":"31","author":"Wang","year":"2024","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coi.2025.102579_sbref41","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/j.cell.2022.06.025","article-title":"Structural mechanisms of GABA(A) receptor autoimmune encephalitis","volume":"185","author":"Noviello","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.coi.2025.102579_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-021-02635-8","article-title":"Multimodal electrophysiological analyses reveal that reduced synaptic excitatory neurotransmission underlies seizures in a model of NMDAR antibody-mediated encephalitis","volume":"4","author":"Wright","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.coi.2025.102579_sbref43","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awae374","article-title":"Parvalbumin neurons mediate neurological phenotypes of anti-NMDAR encephalitis","author":"Feng","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102579_bib44","article-title":"Humoral signatures of MOG-antibody-associated disease track with age and disease activity","volume":"4","author":"Spatola","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.coi.2025.102579_bib45","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1093\/brain\/awae066","article-title":"Distinctive antibody responses to Mycobacterium tuberculosis in pulmonary and brain infection","volume":"147","author":"Spatola","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102579_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2024.09.004","article-title":"Humoral signatures of Caspr2-antibody spectrum disorder track with clinical phenotypes and outcomes","volume":"6","author":"Terroba-Navajas","year":"2025","journal-title":"Med"},{"key":"10.1016\/j.coi.2025.102579_bib47","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","article-title":"Investigations in GABAA receptor antibody-associated encephalitis","volume":"88","author":"Spatola","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.coi.2025.102579_bib48","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.coi.2025.102579_sbref49","article-title":"Encephalitis patient-derived monoclonal GABAA receptor antibodies cause epileptic seizures","volume":"218","author":"Kreye","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2025.102579_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.114838","article-title":"Memory loss and aberrant neurogenesis in mice exposed to patient anti-N-methyl-d-aspartate receptor antibodies","volume":"378","author":"Taraschenko","year":"2024","journal-title":"Exp Neurol"},{"key":"10.1016\/j.coi.2025.102579_sbref51","article-title":"Disrupted callosal connectivity underlies long-lasting sensory-motor deficits in an NMDA receptor antibody encephalitis mouse model","volume":"135","author":"Zhou","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2025.102579_bib52","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.24721","article-title":"Ephrin-B2 prevents N-methyl-D-aspartate receptor antibody effects on memory and neuroplasticity","volume":"80","author":"Planaguma","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coi.2025.102579_bib53","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/brain\/awaa195","article-title":"Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis","volume":"143","author":"Mannara","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102579_sbref54","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1093\/brain\/awac497","article-title":"NMDA-receptor-Fc-fusion constructs neutralize anti-NMDA receptor antibodies","volume":"146","author":"Steinke","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102579_sbref55","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001122","article-title":"Allosteric modulation of NMDARs reverses patients' autoantibody effects in mice","volume":"9","author":"Radosevic","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.coi.2025.102579_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awaf096","article-title":"Activated alphabeta T- and reduced mucosa-associated invariant T cells in LGI1- and CASPR2-encephalitis","author":"Esser","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102579_bib57","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1084\/jem.58.1.39","article-title":"Observations on attempts to produce acute disseminated encephalomyelitis in monkeys","volume":"58","author":"Rivers","year":"1933","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2025.102579_bib58","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221322","article-title":"Experimental encephalomyelitis at age 90, still relevant and elucidating how viruses trigger disease","volume":"220","author":"Steinman","year":"2023","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2025.102579_bib59","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200275","article-title":"MOG CNS autoimmunity and MOGAD","volume":"11","author":"Moseley","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.coi.2025.102579_bib60","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00401-016-1559-8","article-title":"Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen","volume":"132","author":"Kinzel","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.coi.2025.102579_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw0044","article-title":"Autoimmune receptor encephalitis in mice induced by active immunization with conformationally stabilized holoreceptors","volume":"11","author":"Jones","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2025.102579_sbref62","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-021-02107-0","article-title":"Anti-NMDAR encephalitis induced in mice by active immunization with a peptide from the amino-terminal domain of the GluN1 subunit","volume":"18","author":"Ding","year":"2021","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.coi.2025.102579_bib63","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1093\/brain\/awaa250","article-title":"Autoimmune encephalitis mediated by B-cell response against N-methyl-d-aspartate receptor","volume":"143","author":"Wagnon","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102579_bib64","doi-asserted-by":"crossref","first-page":"11082","DOI":"10.1523\/JNEUROSCI.0064-12.2012","article-title":"Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain","volume":"32","author":"Gleichman","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.coi.2025.102579_sbref65","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1211119","article-title":"A juvenile mouse model of anti-N-methyl-D-aspartate receptor encephalitis by active immunization","volume":"16","author":"He","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.coi.2025.102579_bib66","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2023.13120","article-title":"Autoimmune receptor encephalitis in ApoE(\u2011\/\u2011) mice induced by active immunization with NMDA1","volume":"28","author":"Yu","year":"2023","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.coi.2025.102579_sbref67","article-title":"Neuro-immunobiology and treatment assessment in a mouse model of anti-NMDAR encephalitis","author":"Maudes","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102579_bib68","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1093\/brain\/awac088","article-title":"Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis","volume":"145","author":"Al-Diwani","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102579_sbref69","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200080","article-title":"CAR-T cell-mediated B-cell depletion in central nervous system autoimmunity","volume":"10","author":"Gupta","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.coi.2025.102579_bib70","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1016\/j.cell.2023.10.001","article-title":"Chimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells","volume":"186","author":"Reincke","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.coi.2025.102579_bib71","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1523\/JNEUROSCI.1689-21.2022","article-title":"Patient-derived anti-NMDAR antibody disinhibits cortical neuronal networks through dysfunction of inhibitory neuron output","volume":"42","author":"Andrzejak","year":"2022","journal-title":"J Neurosci"},{"key":"10.1016\/j.coi.2025.102579_sbref72","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ana.26362","article-title":"Human metabotropic glutamate receptor 5 antibodies alter receptor levels and behavior in mice","volume":"92","author":"Maudes","year":"2022","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coi.2025.102579_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/cells11061024","article-title":"Pilot study of the effects of chronic intracerebroventricular infusion of human anti-IgLON5 disease antibodies in mice","volume":"11","author":"Alvente","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.coi.2025.102579_bib74","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-022-02520-z","article-title":"Anti-IgLON5 antibodies cause progressive behavioral and neuropathological changes in mice","volume":"19","author":"Ni","year":"2022","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.coi.2025.102579_bib75","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ana.26345","article-title":"Human CASPR2 antibodies reversibly alter memory and the CASPR2 protein complex","volume":"91","author":"Joubert","year":"2022","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coi.2025.102579_bib76","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.neuron.2018.01.033","article-title":"Immune or genetic-mediated disruption of CASPR2 causes pain hypersensitivity due to enhanced primary afferent excitability","volume":"97","author":"Dawes","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.coi.2025.102579_bib77","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1093\/cercor\/bhz032","article-title":"Disrupted AMPA receptor function upon genetic- or antibody-mediated loss of autism-associated CASPR2","volume":"29","author":"Fernandes","year":"2019","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.coi.2025.102579_bib78","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ana.25832","article-title":"Glycine receptor autoantibodies impair receptor function and induce motor dysfunction","volume":"88","author":"Rauschenberger","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coi.2025.102579_bib79","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1093\/brain\/awz297","article-title":"Glycine receptor autoantibodies disrupt inhibitory neurotransmission","volume":"142","author":"Crisp","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.coi.2025.102579_bib80","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/s41380-017-0011-3","article-title":"Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model","volume":"24","author":"Pan","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.coi.2025.102579_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1177672","article-title":"Optimizing animal models of autoimmune encephalitis using active immunization","volume":"14","author":"Linnoila","year":"2023","journal-title":"Front Immunol"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095279152500055X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095279152500055X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:07:44Z","timestamp":1779084464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095279152500055X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":81,"alternative-id":["S095279152500055X"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2025.102579","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal models of autoimmune encephalitis","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2025.102579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102579"}}